Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

A 3242Sesión 222

Qué cambió entre versiones

84 párrafos cambiaron+1454 palabras agregadas−664 eliminadas

El texto resaltado se agregó en la versión más reciente. El texto tachado se eliminó.

LEGISLATIVE FISCAL ESTIMATE

[First Reprint]

ASSEMBLY, No. 3242

STATE OF NEW JERSEY

222nd LEGISLATURE

DATED: FEBRUARY 27, 2026

SUMMARY

Synopsis:

PRE-FILED FOR INTRODUCTION IN THE 2026 SESSION

Sponsored by:

Assemblyman DAN HUTCHISON

District 4 (Atlantic, Camden and Gloucester)

Assemblywoman MARGIE DONLON, M.D.

District 11 (Monmouth)

Assemblywoman HEATHER SIMMONS

District 3 (Cumberland, Gloucester and Salem)

Co-Sponsored by:

Assemblyman Miller, Assemblywomen Bagolie, Reynolds-Jackson, Assemblymen Sampson and Venezia

SYNOPSIS

Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.

Type of Impact:

Annual expenditure increase to State and local government employers.

Agencies Affected:

Division of Pensions and Benefits in the Department of the Treasury; certain local government employers; Department of Banking and Insurance.

Office of Legislative Services Estimate

Fiscal Impact

Annual

State Expenditure Increase for SHBP

$10,800

Local Expenditure Increase for SHBP/SEHBP

$18,000

Total Expenditure Increase for SHBP/SEHBP

$28,800

Local Expenditure Increase for Private Market Insurance

Indeterminate

· The Office of Legislative Services (OLS) estimates that requiring the State Health Benefits Program and the School Employees’ Health Benefits Program to provide health insurance coverage for continuous glucose monitoring systems for the treatment of glycogen storage disease will annually increase State expenditures by approximately $10,800 and participating local government expenditures by approximately $18,000, for a combined total annual expenditure increase of $28,800.

· The OLS notes that local government employers, including school districts, which provide employee health insurance coverage through the private market, could also experience an indeterminate increase in annual costs.

BILL DESCRIPTION

This bill requires health insurers, including the State Health Benefits Program and the School Employees’ Health Benefits Program, to provide coverage for a continuous glucose monitoring system for the treatment of glycogen storage disease.

FISCAL ANALYSIS

EXECUTIVE BRANCH

The OLS has not received a formal fiscal note on this bill. The New Jersey Mandated Health Benefits Advisory Commission submitted a report on a previous version of this bill, Assembly Bill No. 4628 of the 2024-2025 Session, to the General Assembly on May 16, 2025. The commission indicated in its report that “[t]he average cost of [continuous glucose monitors] typically falls in a price range of $1,200-$3,600 per year.”

OFFICE OF LEGISLATIVE SERVICES

The OLS estimates that requiring the State Health Benefits Program and the School Employees’ Health Benefits Program to provide health insurance coverage for continuous glucose monitoring systems for the treatment of glycogen storage disease will annually increase State expenditures by approximately $10,800 and participating local government expenditures by approximately $18,000, for a combined total annual expenditure increase of $28,800. Local government employers, including school districts, which provide employee health insurance coverage through the private market, could also experience an indeterminate increase in annual costs.

Research indicates that glycogen storage disease occurs in approximately 1 in 100,000 people. This rate leads to an estimate of approximately eight people in total having glycogen storage disease that are covered under the State Health Benefits Program and the School Employees’ Health Benefits Program. Under the bill, the State Health Benefits Program is estimated to provide coverage for approximately five people with glycogen storage disease, with three being covered by the State part and two being covered by the local part. The School Employees’ Health Benefits Program is estimated to provide coverage for approximately three people with glycogen storage disease.

Under the bill, the State is required to provide coverage for a continuous glucose monitoring system. Each system has an upwards annual cost of $3,600, leading to increased State expenditures of approximately $10,800 and increased local government expenditures of approximately $18,000, for a combined total estimated expenditure increase of approximately $28,800. The OLS does not know the exact extent to which the programs will cover the continuous glucose monitoring system, as this will depend on decisions made by the State Health Benefits Commission and the School Employees’ Health Benefits Commission. This will ultimately impact costs for the State and participating local governments resulting from the provisions of the bill.

Section:

State Government

Analyst:

Camryn Mathews

Associate Fiscal Analyst

Approved:

Thomas Koenig

Legislative Budget and Finance Officer

This legislative fiscal estimate has been produced by the Office of Legislative Services due to the failure of the Executive Branch to respond to our request for a fiscal note.

This fiscal estimate has been prepared pursuant to P.L.1980, c.67 (C.52:13B-6 et seq.).

CURRENT VERSION OF TEXT

As reported by the Assembly Financial Institutions and Insurance Committee on February 12, 2026, with amendments.

An Act concerning health benefits coverage and continuous glucose monitoring systems and supplementing various parts of the statutory law.

Be It Enacted by the Senate and General Assembly of the State of New Jersey:

1. a. A hospital service corporation contract that provides hospital and medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to P.L.1938, c.366 (C.17:48-1 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease.

b. The benefits shall be provided to the same extent as for any other medical condition under the contract.

c. This section shall apply to those hospital service corporation contracts in which the hospital service corporation has reserved the right to change the premium.

2. a. A medical service corporation contract that provides hospital and medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to P.L.1940, c.74 (C.17:48A-1 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease.

b. The benefits shall be provided to the same extent as for any other medical condition under the contract.

c. This section shall apply to those medical service corporation contracts in which the medical service corporation has reserved the right to change the premium.

3. a. A health service corporation contract that provides hospital and medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to P.L.1985, c.236 (C.17:48E-1 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease.

b. The benefits shall be provided to the same extent as for any other medical condition under the contract.

c. This section shall apply to those health service corporation contracts in which the health service corporation has reserved the right to change the premium.

4. a. An individual health insurance policy that provides hospital and medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to N.J.S.17B:26-1 et seq., or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease.

b. The benefits shall be provided to the same extent as for any other medical condition under the policy.

c. This section shall apply to those individual health insurance policies in which the insurer has reserved the right to change the premium.

5. a. A group health insurance policy that provides hospital and medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to N.J.S.17B:27-26 et seq., or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease.

b. The benefits shall be provided to the same extent as for any other medical condition under the policy.

c. This section shall apply to those group health insurance policies in which the insurer has reserved the right to change the premium.

6. a. An individual health benefits plan that provides hospital and medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to P.L.1992, c.161 (C.17B:27A-2 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease.

b. The benefits shall be provided to the same extent as for any other medical condition under the plan.

c. This section shall apply to those health benefits plans in which the carrier has reserved the right to change the premium.

7. a. A small employer health benefits plan that provides hospital and medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to P.L.1992, c.162 (C.17B:27A-17 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease.

b. The benefits shall be provided to the same extent as for any other medical condition under the plan.

c. This section shall apply to those health benefits plans in which the carrier has reserved the right to change the premium.

8. a. A health maintenance organization contract for health care services that is delivered, issued, executed, or renewed in this State pursuant to P.L.1973, c.337 (C.26:2J-1 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease.

b. The benefits shall be provided to the same extent as for any other medical condition under the contract.

c. This section shall apply to those contracts for health care services under which the health maintenance organization has reserved the right to change the schedule of charges for enrollee coverage.

9. a. The State Health Benefits Commission shall ensure that every contract purchased by the commission on or after the effective date of this act that provides hospital and medical expense benefits shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease.

b. The benefits shall be provided to the same extent as for any other medical condition under the contract.

10. a. The School Employees’ Health Benefits Commission shall ensure that every contract purchased by the commission on or after the effective date of this act that provides hospital and medical expense benefits shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease.

b. The benefits shall be provided to the same extent as for any other medical condition under the contract.

11. This act shall take effect on the first day of the seventh month next following enactment and shall apply to 1 [ all health benefits plans ] policies and contracts 1 that are delivered, issued, executed 1 [ or ] , 1 renewed 1 [ in this State ] 1 , or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act 1 , except that section 6 of this act shall take effect and apply to policies and contracts that are delivered, issued, executed, or renewed pursuant to P.L.1992, c.161 (C.17B:27A-2 et seq.) on January 1, 2027 1 .

Volver al texto completo